Report #2890842

Received Mar 26, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Rash

Symptom narrative

face break out 3 days later; This non-serious case was reported by a other health professional via call center representative and described the occurrence of eruption facial in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, 3 days after receiving Shingrix, the patient experienced eruption facial (Verbatim: face break out 3 days later). The outcome of the eruption facial was unknown. It was unknown if the reporter considered the eruption facial to be related to Shingrix. It was unknown if the company considered the eruption facial to be related to Shingrix. Additional Information: GSK Receipt Date: 17-MAR-2026 The batch number was not provided, and we are unable to contact the reporter.